Testing anaprazole for moderate to severe reflux esophagitis
Part of Digestive system clinical trials.
This trial tests a new medicine called anaprazole for people with moderate to severe reflux esophagitis (chronic heartburn and damage to the food pipe). It compares anaprazole to a standard treatment to see which works better and is safer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have moderate to severe reflux esophagitis (grade B, C, or D) confirmed by a recent endoscopy.
- You have not taken strong heartburn medicines (proton pump inhibitors like omeprazole or rabeprazole) in the 2 weeks before the trial starts.
- You do not have serious uncontrolled health problems, including heart, liver, kidney, or lung disease, or a history of cancer.
- You are not pregnant, planning to become pregnant, or breastfeeding during the trial and for 6 months after.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication, JP-1366, for people with reflux esophagitis (damage to the esophagus from stomach acid). It aims to see if the drug is safe and effective at healing the esophagus and relieving symptoms like heartburn and regurgitation.
This trial tests vonaprazan (two doses) against esomeprazole to see which better heals moderate-to-severe reflux esophagitis (a damaged esophagus from acid reflux) in 8 weeks. You may qualify if you have had heartburn or regurgitation for at least a month and your doctor found grade B, C, or D damage on an endoscopy.
This trial studies whether an endoscopy procedure using APC (a type of heat/energy treatment) can improve symptoms in people with chronic GERD and confirmed acid reflux. It may help reduce reflux-related discomfort for people who meet specific testing and safety requirements.
This trial tests a type of brain-gut medicine to see if it helps with ongoing esophagus problems like heartburn, acid reflux, a lump in the throat, trouble swallowing, or chest pain. It might help if other treatments haven't worked well.
This trial tests whether a new medication called anaprazole sodium, combined with other antibiotics and bismuth, can effectively cure a common stomach bacteria infection called Helicobacter pylori (H. pylori). If you have this infection and have never been treated for it before, this study might help you while contributing to medical knowledge.
This trial tests a new way to treat GERD (chronic acid reflux) using a tiny camera and a device that delivers a gentle heat treatment (argon plasma coagulation) to the area where the stomach meets the esophagus. It's compared to a 'sham' procedure (you won't know which you get) to see if it stops acid from backing up better than medicine alone.
Hear when a new Reflux Esophagitis (RE) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.